Speech-Language Pathologists in Hugo, OK Accepting Medicare
4 Speech-Language Pathologists found. Showing 1 - 4
 Michele Carol Darity, M.S.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1001 Heritage Way, Hugo, OK 74743 Phone: 580-509-9125 Fax: 580-326-8850 |
Rachell Leigh Brumley, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2607 E 2064 Rd, Hugo, OK 74743 Phone: 580-743-7277 |
Mrs. Malinda Gail Pollard, M.S., CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 410 N M St, Hugo, OK 74743 Phone: 580-326-7561 Fax: 580-326-4957 |
Jannita Lynn Daniel, M.S., CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1887 Enchanted Ln, Hugo, OK 74743 Phone: 580-326-4433 |
News Archive
TKR surgeries have more than doubled over the past decade
New research presented at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) found that more than 4.5 million Americans are living with a total knee replacement (TKR), as the number of TKR surgeries has more than doubled over the past decade, with the sharpest rise among younger patients. Osteoarthritis continues to be the primary reason for TKR.
MedImmune abstracts on influenza and RSV to be presented at PAS meeting
MedImmune announced today it will present 11 abstracts at the Pediatric Academic Societies Meeting at the Colorado Convention Center in Denver, CO, April 30 - May 3, 2011.
Bayer Schering collaborates with Ligon to apply SMM technology for first-in-class drug discovery
Ligon Discovery, the innovator of Small Molecule Microarray technology, today announced that it has partnered with Bayer Schering Pharma AG, Germany, to apply its proprietary Small Molecule Microarray screening platform (SMM) to discover potential first-in-class drug candidates for new disease targets.
Reduced exercise capacity linked to neurocognitive problems in survivors of childhood ALL
A new study found a link between reduced exercise capacity and neurocognitive problems in survivors of acute lymphoblastic leukemia, the most common childhood cancer.
High PD-L1 expression linked to reduced survival in NSCLC
Overexpression of programmed death-ligand 1 is independently associated with the presence of epidermal growth factor receptor gene mutations and poor prognosis in patients with non-small-cell lung cancer, Japanese researchers report.
› Verified 8 days ago